Journal of Antimicrobial Chemotherapy · 2003 · 473 citations · 20 references
MedicineMedicinal ChemistryPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyMolecular PharmacologyAntibacterial PharmacologyAntimicrobial PharmacodynamicsTransporter PharmacologyTuberculosis CareTuberculosis Infection ControlTuberculosis PharmacotherapyMembrane Potential DisruptionMembrane Transport EnergeticsMycobacterium Tuberculosis InfectionMycobacterium Tuberculosis PathogenesisTuberculosis ChemoprophylaxisTuberculosis Drug DevelopmentTuberculosis Drug Resistance
Pyrazinamide is an important sterilizing drug that shortens tuberculosis (TB) therapy. However, the mechanism of action of pyrazinamide is poorly understood because of its unusual properties. Here we show that pyrazinoic acid, the active moiety of pyrazinamide, disrupted membrane energetics and inhibited membrane transport function in Mycobacterium tuberculosis. The preferential activity of pyrazinamide against old non-replicating bacilli correlated with their low membrane potential and the disruption of membrane potential by pyrazinoic acid and acid pH. Inhibitors of membrane energetics increased the antituberculous activity of pyrazinamide. These findings shed new light on the mode of action of pyrazinamide and may help in the design of new drugs that shorten therapy.
20
The curious characteristics of pyrazinamide: a review.
Y Zhang, D.A. Mitchison · PubMed · 2003 · 596 citations
Function of Lipophilic Acids as Antimicrobial Food Additives
Ernst Freese, C.W. Sheu, E. M. GALLIERS · Nature · 1973 · 548 citations
The action of antituberculosis drugs in short-course chemotherapy
D.A. Mitchison · Tubercle · 1985 · 512 citations